<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Solara Active Pharma Sciences Ltd. — News on 6ix</title>
<link>https://6ix.com/company/solara-active-pharma-sciences-limited</link>
<description>Latest news and press releases for Solara Active Pharma Sciences Ltd. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Fri, 15 May 2026 07:52:05 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/solara-active-pharma-sciences-limited" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68364ffb78dffbe2df15520a.webp</url>
<title>Solara Active Pharma Sciences Ltd.</title>
<link>https://6ix.com/company/solara-active-pharma-sciences-limited</link>
</image>
<item>
<title>Press Release May 15 2026</title>
<link>https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-may-15-2026-32</link>
<guid isPermaLink="true">https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-may-15-2026-32</guid>
<pubDate>Fri, 15 May 2026 07:52:05 GMT</pubDate>
<description>Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated May 15, 2026, titled "Strong Q4 26 Results and a solid finish to the fiscal Year".</description>
</item>
<item>
<title>Press Release Apr 28 2026</title>
<link>https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-apr-28-2026-18</link>
<guid isPermaLink="true">https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-apr-28-2026-18</guid>
<pubDate>Tue, 28 Apr 2026 21:01:27 GMT</pubDate>
<description>Solara Active Pharma Sciences Limited has informed the Exchange regarding the press release dated April 28, 2026, titled Solara is pleased to announce the successful closure of US FDA inspection of its Puducherry Facility with continued state of cGMP compliance.</description>
</item>
<item>
<title>Press Release Feb 06 2026</title>
<link>https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-feb-06-2026-47</link>
<guid isPermaLink="true">https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-feb-06-2026-47</guid>
<pubDate>Fri, 06 Feb 2026 19:09:52 GMT</pubDate>
<description>Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."</description>
</item>
<item>
<title>Press Release Nov 19 2025</title>
<link>https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-nov-19-2025-16</link>
<guid isPermaLink="true">https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-nov-19-2025-16</guid>
<pubDate>Wed, 19 Nov 2025 15:27:00 GMT</pubDate>
<description>Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release titled "Solara is pleased to announce the successful closure of US FDA inspection of its Mangalore Facility with continued state of compliance on cGMP".</description>
</item>
<item>
<title>Press Release Nov 05 2025</title>
<link>https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-nov-05-2025-42</link>
<guid isPermaLink="true">https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-nov-05-2025-42</guid>
<pubDate>Wed, 05 Nov 2025 19:41:17 GMT</pubDate>
<description>Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated November 05, 2025, titled "Solara Q2'26 Performance".</description>
</item>
<item>
<title>Press Release Jul 25 2025</title>
<link>https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-jul-25-2025-38</link>
<guid isPermaLink="true">https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-jul-25-2025-38</guid>
<pubDate>Fri, 25 Jul 2025 19:18:50 GMT</pubDate>
<description>Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated July 25, 2025, titled "Solara Q1'26 performance" of the Board Meeting held today i.e. July 25, 2025, to consider the Financial Results for the quarter ended June 30, 2025.</description>
</item>
<item>
<title>Press Release May 15 2025</title>
<link>https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-may-15-2025-51</link>
<guid isPermaLink="true">https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-may-15-2025-51</guid>
<pubDate>Thu, 15 May 2025 20:57:37 GMT</pubDate>
<description>Solara Active Pharma Sciences Limited, has informed the exchange regarding the Press release in connection with Financial Results for the quarter and year ended March 31, 2025.</description>
</item>
<item>
<title>Press Release May 10 2025</title>
<link>https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-may-10-2025-4</link>
<guid isPermaLink="true">https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-may-10-2025-4</guid>
<pubDate>Sat, 10 May 2025 19:43:00 GMT</pubDate>
<description>Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated May 10, 2025, titled "Completion of USFDA inspection in Ambernath facility".</description>
</item>
<item>
<title>Press Release Jan 24 2025</title>
<link>https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-jan-24-2025-41</link>
<guid isPermaLink="true">https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-jan-24-2025-41</guid>
<pubDate>Fri, 24 Jan 2025 22:07:01 GMT</pubDate>
<description>Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated January 24, 2025, titled "Solara Q3 25 performance" for the Financial Results for the quarter ended December 31, 2024</description>
</item>
<item>
<title>Press Release Jul 31 2024</title>
<link>https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-jul-31-2024-41</link>
<guid isPermaLink="true">https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-jul-31-2024-41</guid>
<pubDate>Wed, 31 Jul 2024 18:41:35 GMT</pubDate>
<description>Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated July 31, 2024, titled "Completion of the EU - GMP inspection at the Puducherry facility".</description>
</item>
<item>
<title>Press Release Jun 12 2024</title>
<link>https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-jun-12-2024-18</link>
<guid isPermaLink="true">https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-jun-12-2024-18</guid>
<pubDate>Wed, 12 Jun 2024 15:46:36 GMT</pubDate>
<description>Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated Jun 12, 2024, titled " Solara announces closure of Rights Issue".</description>
</item>
<item>
<title>Press Release May 20 2024</title>
<link>https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-may-20-2024-15</link>
<guid isPermaLink="true">https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-may-20-2024-15</guid>
<pubDate>Mon, 20 May 2024 14:05:25 GMT</pubDate>
<description>Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated May 20, 2024, titled "USFDA concludes inspection at Solara s Visakhapatnam Facility with Zero 483 inspectional observations.".</description>
</item>
<item>
<title>Press Release May 09 2024</title>
<link>https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-may-09-2024-35</link>
<guid isPermaLink="true">https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-may-09-2024-35</guid>
<pubDate>Thu, 09 May 2024 23:12:15 GMT</pubDate>
<description>Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated May 09, 2024, titled "Solara finalizes Rights Issue terms".</description>
</item>
<item>
<title>Press Release Aug 07 2023</title>
<link>https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-aug-07-2023-49</link>
<guid isPermaLink="true">https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-aug-07-2023-49</guid>
<pubDate>Mon, 07 Aug 2023 12:27:01 GMT</pubDate>
<description>Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated August 07, 2023, titled "Completion of the USFDA Inspection at the Cuddalore facility of the Company".</description>
</item>
<item>
<title>Press Release Feb 13 2023</title>
<link>https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-feb-13-2023-34</link>
<guid isPermaLink="true">https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-feb-13-2023-34</guid>
<pubDate>Mon, 13 Feb 2023 16:10:51 GMT</pubDate>
<description>Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated February 13, 2023, titled "Completion of the EU-GMP inspection at the Cuddalore facility of the Company".</description>
</item>
<item>
<title>Press Release Jan 30 2023</title>
<link>https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-jan-30-2023-25</link>
<guid isPermaLink="true">https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-jan-30-2023-25</guid>
<pubDate>Mon, 30 Jan 2023 14:52:57 GMT</pubDate>
<description>Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated January 30, 2023, titled " USFDA concludes inspection at Solara s Visakhapatnam (Vizag) facility with zero 483 inspectional observations. ".</description>
</item>
<item>
<title>Press Release Jan 27 2023</title>
<link>https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-jan-27-2023-12</link>
<guid isPermaLink="true">https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-jan-27-2023-12</guid>
<pubDate>Fri, 27 Jan 2023 15:09:09 GMT</pubDate>
<description>Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated January 27, 2023, titled "Completion of the WHO PQ inspection at the Cuddalore facility of the Company.".</description>
</item>
<item>
<title>Press Release Nov 01 2022</title>
<link>https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-nov-01-2022-28</link>
<guid isPermaLink="true">https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-nov-01-2022-28</guid>
<pubDate>Tue, 01 Nov 2022 14:19:20 GMT</pubDate>
<description>Solara Active Pharma Sciences Limited has informed the Exchange about press release dated 01-Nov-2022 titled Solara receives European Approval (CEP) to manufacture Ibuprofen from its flagship Vizag facility</description>
</item>
<item>
<title>Press Release Jul 02 2021</title>
<link>https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-jul-02-2021-13</link>
<guid isPermaLink="true">https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-jul-02-2021-13</guid>
<pubDate>Fri, 02 Jul 2021 18:29:45 GMT</pubDate>
<description>Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated July 02, 2021, titled "Restoration of CEP for Ranitidine Hydrochloride Drug Substance granted by EDQM.".</description>
</item>
<item>
<title>Press Release May 18 2021</title>
<link>https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-may-18-2021-13</link>
<guid isPermaLink="true">https://6ix.com/company/solara-active-pharma-sciences-limited/news/press-release-may-18-2021-13</guid>
<pubDate>Tue, 18 May 2021 18:11:21 GMT</pubDate>
<description>Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated May 18, 2021, titled "Promoter pledge reduces by 50%".</description>
</item>
</channel>
</rss>